74 related articles for article (PubMed ID: 2769481)
21. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
Masiuk M
Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
[TBL] [Abstract][Full Text] [Related]
22. Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study.
Crabb SJ; Bajdik CD; Leung S; Speers CH; Kennecke H; Huntsman DG; Gelmon KA
Breast Cancer Res; 2008; 10(1):R6. PubMed ID: 18194560
[TBL] [Abstract][Full Text] [Related]
23. Oestrogen and progesterone receptor status of individual foci in multifocal invasive ductal breast cancer.
Garimella V; Long ED; O'Kane SL; Drew PJ; Cawkwell L
Acta Oncol; 2007; 46(2):204-7. PubMed ID: 17453370
[TBL] [Abstract][Full Text] [Related]
24. Vimentin--a new prognostic parameter in breast carcinoma?
Raymond WA; Leong AS
J Pathol; 1989 Jun; 158(2):107-14. PubMed ID: 2547048
[TBL] [Abstract][Full Text] [Related]
25. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue].
Schulze MH; Buchmann J
Zentralbl Gynakol; 2000; 122(2):92-5. PubMed ID: 10721188
[TBL] [Abstract][Full Text] [Related]
26. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
[TBL] [Abstract][Full Text] [Related]
27. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP.
Schneider J; Lucas R; Sánchez J; Ruibal A; Tejerina A; Martín M
Anticancer Res; 2000; 20(6B):4373-7. PubMed ID: 11205274
[TBL] [Abstract][Full Text] [Related]
28. [Estrogen receptors in cancer of the breast. Comparison of 2 methods].
Delarue JC; Mouriesse H; Contesso G; Bonnay M; May-Levin F; Sancho-Garnier H; Travagli JP; Lacombe MJ
Ann Biol Clin (Paris); 1986; 44(6):629-33. PubMed ID: 3548499
[TBL] [Abstract][Full Text] [Related]
29. Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth fractions, estrogen receptor status and morphological criteria. An immunohistochemical study.
Wrba F; Reiner A; Ritzinger E; Holzner JH; Reiner G
Pathol Res Pract; 1988 Feb; 183(1):25-9. PubMed ID: 3362749
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC).
Beck T; Weikel W; Brumm C; Wilkens C; Pollow K; Knapstein PG
Gynecol Oncol; 1994 May; 53(2):220-7. PubMed ID: 8188083
[TBL] [Abstract][Full Text] [Related]
31. A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer.
Woo SU; Bae JW; Kim CH; Lee JB; Koo BW
Ann Surg Oncol; 2008 Jan; 15(1):281-5. PubMed ID: 17763975
[TBL] [Abstract][Full Text] [Related]
32. The clinical application of oestrogen receptor analysis in early cancer of the breast.
Cooke T
Ann R Coll Surg Engl; 1982 May; 64(3):165-70. PubMed ID: 7081915
[TBL] [Abstract][Full Text] [Related]
33. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
Bartlett JM; Ellis IO; Dowsett M; Mallon EA; Cameron DA; Johnston S; Hall E; A'Hern R; Peckitt C; Bliss JM; Johnson L; Barrett-Lee P; Ellis P
J Clin Oncol; 2007 Oct; 25(28):4423-30. PubMed ID: 17906205
[TBL] [Abstract][Full Text] [Related]
34. Biologic tumor markers, lymph node status, and decision about adjuvant chemotherapy for breast cancer.
Velanovich V
Am Surg; 1997 Apr; 63(4):330-3. PubMed ID: 9124752
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical correlation of steroid receptors and disease-free interval in 206 consecutive cases of breast cancer: validation of telequantification based on global scene segmentation.
Ferrer Roca OF; Ramos A; Diaz Cardama A
Anal Cell Pathol; 1995 Sep; 9(2):151-63. PubMed ID: 7492518
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancer.
Berry N; Jones DB; Smallwood J; Taylor I; Kirkham N; Taylor-Papadimitriou J
Br J Cancer; 1985 Feb; 51(2):179-86. PubMed ID: 2578285
[TBL] [Abstract][Full Text] [Related]
37. Ki-67 immunoreactivity in breast carcinomas in relation to transferrin receptor expression, estrogen receptor status and morphological criteria. An immunohistochemical study.
Wrba F; Chott A; Reiner A; Reiner G; Markis-Ritzinger E; Holzner JH
Oncology; 1989; 46(4):255-9. PubMed ID: 2662089
[TBL] [Abstract][Full Text] [Related]
38. Localization of metallothionein in breast carcinomas. An immunohistochemical study.
Fresno M; Wu W; Rodriguez JM; Nadji M
Virchows Arch A Pathol Anat Histopathol; 1993; 423(3):215-9. PubMed ID: 8236816
[TBL] [Abstract][Full Text] [Related]
39. Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator.
Ellis IO; Hinton CP; MacNay J; Elston CW; Robins A; Owainati AA; Blamey RW; Baldwin RW; Ferry B
Br Med J (Clin Res Ed); 1985 Mar; 290(6472):881-3. PubMed ID: 3919829
[TBL] [Abstract][Full Text] [Related]
40. Correlation between immunohistochemically determined oestrogen receptor content, using monoclonal antibodies, and qualitative and quantitative tissue features in ductal breast cancer.
Tosi P; Baak JP; Luzi P; Sforza V; Santopietro R; Lio R
Histopathology; 1987 Jul; 11(7):741-51. PubMed ID: 3040566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
